stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. MCRT
    stockgist
    HomeTop MoversCompaniesConcepts
    MCRT logo

    Microart Inc.

    MCRT
    OTC
    Healthcare
    Biotechnology
    Kowloon City, HK
    —

    At A Glance

    1

    Microart Inc.

    2

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Fundamentals

    How The Business Makes Money

    Microart Inc. researches and develops innovative stem cell solutions and therapeutic applications of adult stem cells. The company develops and commercializes cell-based anti-aging research and cosmetic products. Microart Inc. also develops proprietary technology for the treatment of diabetes. The company was founded in 1980 and is based in Kowloon City, Hong Kong.

    Industry Biotechnology
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    GMVDFG Medical Innovations Hol...————
    PZOOPazoo, Inc.————
    HAVLFHAVN Life Sciences Inc.————
    VPROViropro Inc.————
    NNBPNanobac Pharmaceuticals, ...————
    CLABFCore One Labs Inc.————
    RLBDReal Brands, Inc.————
    CBDXCurative Biosciences, Inc...————
    Company Profile
    CIKUNKNOWN_MCRT
    ISINUS59502C1027
    Phone852 3111 7718
    Address2611 Office Tower, Kowloon City, HK
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice